GASTROINTESTINAL STROMAL CANCER

This adverse event was reported 42 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL STROMAL CANCER:

# Drug Count
0 REGORAFENIB 15
1 SUNITINIB MALATE 6
2 SORAFENIB 4
3 ADALIMUMAB 3
4 IMATINIB MESYLATE 3
5 APIXABAN 2
6 CARVEDILOL 2
7 ETANERCEPT 2
8 LISINOPRIL 2
9 ANASTROZOLE 1
See all common drugs associated with GASTROINTESTINAL STROMAL CANCER

GASTROINTESTINAL STROMAL CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 REGORAFENIB 15 0.0013
1 CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1 0.0006
2 SORAFENIB 4 0.0002
3 TAMOXIFEN CITRATE 1 0.0002
4 SUNITINIB MALATE 6 0.0002
5 IMATINIB MESYLATE 3 0.0001
6 GOLIMUMAB 1 0.0001
7 LINAGLIPTIN 1 0.0001
8 PAZOPANIB HYDROCHLORIDE 1 0.0000
9 APIXABAN 2 0.0000
See all drugs enriched for association with GASTROINTESTINAL STROMAL CANCER